The polymer pharmaceutical/drug characterization and processing facility

澳大利亚人口正在老龄化，这给我们的卫生系统带来了越来越大的负担。此外，对疾病状态的新理解导致了对用于药物输送和组织再生的改进材料的需求。这一提议将导致设计出满足这些需求的新型生物材料。聚合物被视为构建这种生物医学装置的基本元素，因为它们可以被制成无数种形式，以及大量不同的材料可供选择。这项提议将导致PolyPharma网络的形成，该网络将生产聚合物生物材料，使我们的健康行业受益。

The Australian population is ageing, and this is leading to ever increasing burdens upon our health system. In addition new understanding of disease states has lead to a demand for improved materials for drug delivery and for tissue regeneration. This proposal will lead to novel biomaterials designed to meet these demands. Polymers are seen as essential elements for construction of such biomedical devices due to the myriad forms in which they can be made, and the large number of different materials to choose from. This proposal will lead to the formation of the PolyPharma network which will produce polymeric biomaterials to benefit our health industries.